INTERNATIONAL PATENT: AUTIFONY THERAPEUTICS LIMITED, UNIVERSITA DEGLI STUDI DI PADOVA FILES APPLICATION FOR "KV3 MODULATORS FOR USE IN THE TREATMENT OR PROPHYLAXIS OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)"

GENEVA, May 10 -- AUTIFONY THERAPEUTICS LIMITED (Stevenage Bioscience CatalystGunnels Wood RoadStevenage Hertfordshire SG1 2FX), UNIVERSITA DEGLI STUDI DI PADOVA (Via 8 Febbraio2-35122 Padova) filed a patent application (PCT/EP2025/081278) for "KV3 MODULATORS FOR USE IN THE TREATMENT OR PROPHYLAXIS OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)" on Oct 29, 2025. With publication no. WO/2026/093398, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LARGE, Charles (c/o Autifony Therapeutics LimitedStevenage Bioscience CatalystGunnels...